TAG ARCHIVE

POSTS TAGGED AS genomics

The $1,000 Genome, Pretty Soon

February 7, 2012 | Terry Sharrer | Posted in Newsletter

Ion Torrent, a division of Life Technologies Corporation (Carlsbad, CA) is now taking orders for it’s “Ion Proton” DNA [MORE]

Medicine in the year 2060

January 31, 2012 | Terry Sharrer | Posted in Newsletter

Physicist Michio Kaku predicts how today’s breakthroughs in medicine and healthcare-organ regeneration, nanoparticle drug delivery, implantable robots, “smart” bathrooms, [MORE]

Schizophrenia’s RNA Expression Pattern

December 13, 2011 | Terry Sharrer | Posted in Newsletter

A main aim of genetics in psychiatric epidemiology is to sort out much finer definitions of mental disorders beyond [MORE]

Metabolgenomics

November 15, 2011 | Terry Sharrer | Posted in Newsletter

Metabolic syndrome-that dangerous mix of hypertension, elevated cholesterol and Type 2 diabetes-is both biologically complex and rising in incidence as [MORE]

Twenty-Eight SNPs of Hypertension

November 1, 2011 | Terry Sharrer | Posted in Newsletter

In a European consortium’s study of hypertension, initially involving 70k people, with 133k more for validation, researchers identified 28 [MORE]

“Special Pricing for First Time Customers:” The $5,000 Genome

October 4, 2011 | Terry Sharrer | Posted in Newsletter

It wasn’t too long ago that Knome was offering to sequence an entire human genome for about the [MORE]

The African-American Genome

September 20, 2011 | Terry Sharrer | Posted in Newsletter

Slavery created a selection pressure that favored for survival those individuals who retained water in their blood, since dehydration [MORE]

Single Cell Science

September 20, 2011 | Terry Sharrer | Posted in Newsletter

Genomics scientists at the University of British Columbia have developed an integrated microfluidics device that performs cell capture, lysis, [MORE]

Genetic Engineering: Eliminating the Stop Codon

September 13, 2011 | Terry Sharrer | Posted in Newsletter

Harvard’s George Church, Farren Isaacs, and colleagues have used a technique called “multiplex automated genome engineering” to alter all [MORE]

Semi-Conductor Based Sequencing

September 5, 2011 | Terry Sharrer | Posted in Newsletter

Earlier this year, Tagline carried a story about “desktop sequencing” based on Ion Torrent’s semi-conductor approach which detects DNA [MORE]

Fox Chase’s Cancer Genome Institute

July 19, 2011 | Terry Sharrer | Posted in Newsletter

Life Technologies, Inc. (Carlsbad, CA)-formed from a 2008 merger of Invitrogen Corporation and Applied Biosystems-has reached an agreement with [MORE]

Personal Genome Machine

May 24, 2011 | Terry Sharrer | Posted in Newsletter

Recently, Ion Torrent (Guilford, CT, a branch of Life Technologies-formerly Applied Biosciences) named Ambry Genetics (Aliso Viego, CA) as [MORE]

Testing Breast Cancer Tests

May 17, 2011 | Terry Sharrer | Posted in Newsletter

In 1955, the National Cancer Institute began organizing oncologists into regional study groups to address specific interests that NCI [MORE]

Social Network Analysis for Epidemiology

April 26, 2011 | Terry Sharrer | Posted in Newsletter

Suppose an outbreak of a new antibiotic- resistant pathogen appeared in one place and then another, and onward from [MORE]

Genomics Coaching, Colon Cancer

April 19, 2011 | Terry Sharrer | Posted in Newsletter

A rap against consumer genomics has been the lack of interpreting authority-e.g. what does a 30% increase in risk [MORE]

A Catch-22 for Cancer Survivors

April 12, 2011 | Terry Sharrer | Posted in Newsletter

Surviving cancer can have adverse effects-e.g. cardiovascular complications, obesity, diabetes, osteopenia and osteoporosis, et al. For those reasons, cancer [MORE]

Screening by Sequencing

March 15, 2011 | Terry Sharrer | Posted in Newsletter

In January, Stephen Kingsmore, chief scientific officer for the National Human Genome Research Institute, reported that he and his [MORE]

Brookings Study on IT and Personalized Medicine

February 28, 2011 | Pamela Cipriano | Posted in Newsletter

It has happened before, and often: scientific discovery running ahead of medical practice and public policy, with consumer demand [MORE]

Scripps’ Study of Personal Genomics

February 22, 2011 | Terry Sharrer | Posted in Newsletter

Last year, an FDA report about the superficiality of personalized genomics tests forestalled drug stores selling those kits. Two [MORE]

Problems in Stem Cell Genetics

February 22, 2011 | Terry Sharrer | Posted in Newsletter

Researchers at the University of California, San Diego and the Scripps Research Institute recently made a disturbing discovery [MORE]